Article
Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes
24 Jan 2025
Abstract excerpt
Pathogen mutations present an inevitable and challenging problem for therapeutics and the development of mutation-tolerant anti-infective drugs to strengthen global health and combat evolving pathogens is urgently needed. While spike proteins on viral surfaces are attractive targets for preventing viral entry, they mutate frequently, making it difficult to develop effective therapeutics. Here, we used a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
